| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.97B | -7.0% |
| Cost of Revenue | $37.44B | -2.4% |
| R&D Expense | $752.0M | -7.2% |
| SG&A Expense | $1.39B | -12.0% |
| Interest Expense | $865.0M | +6.7% |
| Pre-tax Income | -$2.51B | -256.9% |
| Income Tax | -$67.0M | -116.8% |
| Net Income | -$2.44B | -303.5% |
| EPS (Basic) | -$3.70 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.82B | +74.3% |
| Accounts Receivable | $4.76B | +0.1% |
| Inventory | $6.59B | +0.8% |
| Current Assets | $18.06B | +8.9% |
| Total Assets | $58.54B | +2.1% |
| Current Liabilities | $9.18B | -10.7% |
| Long-term Debt | $17.85B | +10.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.03B | -64.6% |
| Investing Cash Flow | -$2.13B | +10.2% |
| Financing Cash Flow | $2.51B | +314.7% |
| -335.7% |
| EPS (Diluted) | -$3.70 | -335.7% |
| Stockholders' Equity |
| $16.01B |
| -7.8% |